ロード中...
Update on the Use of L-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia
Great improvements have been made in acute lymphoblastic leukemia (ALL) treatment in the past decades, especially due to the use of L-asparaginase (L-ASP). Despite the significant success rate, several side effects mainly caused by toxicity, asparaginase silent inactivation, and cellular resistance,...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publishing
2014-01-01
|
| シリーズ: | Clinical Medicine Insights: Oncology |
| オンライン･アクセス: | https://doi.org/10.4137/CMO.S10242 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|